Cargando…
Hormone-induced protection of mammary tumorigenesis in genetically engineered mouse models
INTRODUCTION: The experiments reported here address the question of whether a short-term hormone treatment can prevent mammary tumorigenesis in two different genetically engineered mouse models. METHODS: Two mouse models, the p53-null mammary epithelial transplant and the c-neu mouse, were exposed t...
Autores principales: | Rajkumar, Lakshmanaswamy, Kittrell, Frances S, Guzman, Raphael C, Brown, Powel H, Nandi, Satyabrata, Medina, Daniel |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1851398/ https://www.ncbi.nlm.nih.gov/pubmed/17257424 http://dx.doi.org/10.1186/bcr1645 |
Ejemplares similares
-
Prevention of mammary carcinogenesis by short-term estrogen and progestin treatments
por: Rajkumar, Lakshmanaswamy, et al.
Publicado: (2004) -
Insulin-like growth factor (IGF)-I obliterates the pregnancy-associated protection against mammary carcinogenesis in rats: evidence that IGF-I enhances cancer progression through estrogen receptor-α activation via the mitogen-activated protein kinase pathway
por: Thordarson, Gudmundur, et al.
Publicado: (2004) -
Transcriptomic signature of Bexarotene (Rexinoid LGD1069) on mammary gland from three transgenic mouse mammary cancer models
por: Abba, Martin C, et al.
Publicado: (2008) -
Osteopontin is a potential target gene in mouse mammary cancer chemoprevention by Se-methylselenocysteine
por: Unni, Emmanual, et al.
Publicado: (2004) -
TAp63 suppresses mammary tumorigenesis through regulation of the Hippo pathway
por: Su, X, et al.
Publicado: (2017)